Renowned Cancer Researcher to Speak at Medical Center
Monday, April 24, 2006
Judah Folkman, M.D., one of the world’s most famous cancer researchers, will speak Friday, April 28, at the University of Rochester School of Medicine and Dentistry’s annual Marvin J. Hoffman Day award ceremonies.
Folkman, professor of pediatric surgery and cell biology at Harvard Medical School director of the Vascular Biology Program at Children's Hospital in Boston, proposed more than 40 years ago that cancer could be stopped by depriving tumor cells new blood vessel growth – a theory that has come to be known as anti-angiogenesis.
Folkman’s theory took years to gain acceptance. But today, it is a driving force in cancer research and more than two dozen anti-angiogensis drugs are in development. His lab also is working on identifying proteins that signal the presence of cancer. Folkman has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society and the Institute of Medicine of the National Academy of Sciences.
The Center for Advocacy, Community Health, Education and Diversity and the School of Medicine and Dentistry present the annual Marvin J. Hoffman Day. The event highlights medical student participation in community outreach, international medicine, basic science or clinical research and geriatric research. Awards are given for the best student project in each area and to faculty mentors.
This year’s awards will go to a student who studied depression in older adults, a group of students who provide free physicals for students in the Rochester City School District, a student who researched the reactions of mothers in Thailand and the United States to the birth of a child with cleft lip and palate, and a student who conducted a bone growth study.
WHAT: Eight Annual Marvin J. Hoffman Day
WHEN:Friday, April 28, 2006
LOCATION: Class of 1962 Auditorium, Arthur Kornberg Medical Research Building, University of Rochester Medical Center, 601 Elmwood Ave
This event is open to the media.